These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7257674)

  • 1. [Plasma non-ceruloplasmin copper in hepatocerebral dystrophy (criterion for the diagnosis and evaluation of cuprogogue therapy)].
    Botvinnik VS; Lekar' PG; Makarova VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):334-7. PubMed ID: 7257674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocerebral degeneration (Wilson's disease). Demonstration of the clinical picture and demonstration of own case].
    Rosenberger K
    Nervenarzt; 1973 Sep; 44(9):484-7. PubMed ID: 4750027
    [No Abstract]   [Full Text] [Related]  

  • 3. CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease.
    Stuerenburg HJ
    J Neural Transm (Vienna); 2000; 107(3):321-9. PubMed ID: 10821440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Late-onset Wilsońs disease].
    Campos Franco J; Domínguez Santalla MJ; Tomé Martínez de Rituerto S; Otero Antón E; González Quintela A
    An Med Interna; 2003 Aug; 20(8):416-8. PubMed ID: 14516263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma copper and antioxidant status in Wilson's disease.
    Ogihara H; Ogihara T; Miki M; Yasuda H; Mino M
    Pediatr Res; 1995 Feb; 37(2):219-26. PubMed ID: 7731761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of Wilson disease].
    Smolarek C; Stremmel W
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndromic variability of Wilson's disease in children. Clinical study of 44 cases.
    Giacchino R; Marazzi MG; Barabino A; Fasce L; Ciravegna B; Famularo L; Boni L; Callea F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):155-61. PubMed ID: 9646197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 'free' copper in Wilson disease.
    Walshe JM
    QJM; 2012 May; 105(5):419-23. PubMed ID: 22139498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of an enzymatic assay for the determination of serum ceruloplasmin.
    Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW
    J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenocopy of hepatocerebral dystrophy (Wilson-Konovalov disease)].
    Makarova VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1606-12. PubMed ID: 7324659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilson disease.
    Houwen RH; van Hattum J; Hoogenraad TU
    Neth J Med; 1993 Aug; 43(1-2):26-37. PubMed ID: 8232692
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hepatocerebral dystrophy (Wilson-Westphal-Konovalov's disease)].
    Lekar' PG; Makarova VA; Botvinnik VS
    Sov Med; 1981; (6):86-8. PubMed ID: 7280806
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
    Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
    J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
    Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C
    Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of cerebral disorders in hepatocerebral dystrophy].
    Lekar' PG; Makarova VA; Botvinnik VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):346-50. PubMed ID: 2883792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of penicillamine in Wilson-Konovalov disease].
    Vakharlovskiĭ VG; Nikitina LI; Bondarchuk AN
    Klin Med (Mosk); 1980 Jan; 58(1):56-60. PubMed ID: 7366142
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of D-penicillamine on liver fibrosis and inflammation in Wilson disease.
    Kazemi K; Geramizadeh B; Nikeghbalian S; Salahi H; Bahador A; Reza Nejatollahi SM; Dehghani SM; Dehghani M; Kakaei F; Malek-Hosseini SA
    Exp Clin Transplant; 2008 Dec; 6(4):261-3. PubMed ID: 19338486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of zinc, copper and selenium in patients with Wilson's disease treated with zinc].
    Dastych M
    Vnitr Lek; 1999 Apr; 45(4):217-9. PubMed ID: 11045182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the protective effects on the erythrocytes of ceruloplasmin from the blood of healthy donors and patients with hepatocerebral dystrophy].
    Saenko EL; Skorobagat'ko OV; Iaropolov AI
    Biull Eksp Biol Med; 1990 Oct; 110(10):368-70. PubMed ID: 2279084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.